ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine (azacitidine)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01180322
Recruitment Status : Unknown
Verified August 2013 by Dr. Richard Schlenk, University of Ulm.
Recruitment status was:  Active, not recruiting
First Posted : August 12, 2010
Last Update Posted : September 2, 2013
Sponsor:
Information provided by (Responsible Party):
Dr. Richard Schlenk, University of Ulm

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Actual Primary Completion Date : June 2012
  Estimated Study Completion Date : October 2016